Related references
Note: Only part of the references are listed.Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)
Lucie Lafay-Cousin et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on Head Start III: a multi-institutional, prospective clinical trial
Girish Dhall et al.
NEURO-ONCOLOGY (2020)
Relevance of the Type and Timing of Radiation Therapy to the Outcomes Reported in the ACNS0333 Trial for Atypical Teratoid/Rhabdoid Tumors Reply
Alyssa T. Reddy et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Giles W. Robinson et al.
LANCET ONCOLOGY (2018)
DNA methylation-based classification of central nervous system tumours
David Capper et al.
NATURE (2018)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy
Lucie Lafay-Cousin et al.
PEDIATRIC BLOOD & CANCER (2016)
Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape
Amar Gajjar et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group
Bruce H. Cohen et al.
PEDIATRIC NEUROLOGY (2015)
High-Dose Busulfan-Thiotepa With Autologous Stem Cell Transplantation Followed by Posterior Fossa Irradiation in Young Children With Classical or Incompletely Resected Medulloblastoma
Guillaume Bergthold et al.
PEDIATRIC BLOOD & CANCER (2014)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Induction Chemotherapy and Conformal Radiation Therapy for Very Young Children With Nonmetastatic Medulloblastoma: Children's Oncology Group Study P9934
David M. Ashley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival
Laura Negretti et al.
NEURO-ONCOLOGY (2012)
Histology Predicts a Favorable Outcome in Young Children With Desmoplastic Medulloblastoma
Sarah E. S. Leary et al.
CANCER (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
David W. Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
Maryam Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Frequent Amplification of a chr19q13.41 MicroRNA Polycistron in Aggressive Primitive Neuroectodermal Brain Tumors
Meihua Li et al.
CANCER CELL (2009)
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy
Stefan Rutkowski et al.
NEURO-ONCOLOGY (2009)
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the Head Start I and II protocols
Girish Dhall et al.
PEDIATRIC BLOOD & CANCER (2008)
Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumor (sPNETs): Report of the head start I and II experience
Jason Fangusaro et al.
PEDIATRIC BLOOD & CANCER (2008)
Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA)
Susan E. Spiller et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma
Susan E. Spiller et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the children's cancer group
JR Geyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies
M Fouladi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Intrathecal mafosfamide: A preclinical pharmacology and phase I trial
SM Blaney et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma
SN Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
